VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $400,000 | -16.7% | 25,100 | +8.7% | 0.05% | -34.6% |
| Q4 2017 | $480,000 | -16.5% | 23,100 | -42.4% | 0.08% | -13.3% |
| Q3 2017 | $575,000 | -17.3% | 40,099 | -0.2% | 0.09% | -21.7% |
| Q2 2017 | $695,000 | -60.7% | 40,199 | -74.9% | 0.12% | -71.8% |
| Q1 2017 | $1,768,000 | -31.7% | 160,299 | -10.1% | 0.41% | -47.8% |
| Q4 2016 | $2,589,000 | +0.0% | 178,299 | +81.2% | 0.78% | -21.2% |
| Q1 2016 | $2,588,000 | – | 98,400 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |